{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:18:36Z","timestamp":1791357516169,"version":"4.3.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,10,30]],"date-time":"2020-10-30T00:00:00Z","timestamp":1604016000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,10,30]],"date-time":"2020-10-30T00:00:00Z","timestamp":1604016000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Ministry of Education, Science and Sport of the Republic of Slovenia","award":["P3-0289"],"award-info":[{"award-number":["P3-0289"]}]},{"name":"Krka, d.d., Novo mesto","award":["Trial KCT 04\/2015-doretaonko\/si"],"award-info":[{"award-number":["Trial KCT 04\/2015-doretaonko\/si"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The objective of this study was to evaluate the severity of acute pain and side effects in breast cancer patients postoperatively treated with two regimens of tramadol with paracetamol in a prospective double-blind study. Altogether 117 breast cancer patients who had axillary lymphadenectomy were randomized into two analgesic study groups and the analgesic treatment lasted 4\u00a0weeks. Stronger analgesia group received every 8\u00a0h 75\/650\u00a0mg of tramadol with paracetamol, while weaker analgesia group received every 8\u00a0h 37.5\/325\u00a0mg of tramadol with paracetamol. Patients with the higher dose of tramadol had less pain during the 1st and 4th week than patients with the lower dose. Frequency of nausea, vomiting, lymphedema or range of shoulder movement was not significantly different between the two groups of patients. Constipation was significantly more common in the group with stronger analgesia during the 2nd week in comparison to patients with weaker analgesia. The patients who were on 75\/650\u00a0mg of tramadol with paracetamol had less pain in comparison to patients who were on 37.5\/325\u00a0mg. Side effects were mild, but common in both groups of patients.<\/jats:p>","DOI":"10.1038\/s41598-020-75961-2","type":"journal-article","created":{"date-parts":[[2020,10,30]],"date-time":"2020-10-30T11:03:14Z","timestamp":1604055794000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Acute pain and side effects after tramadol in breast cancer patients: results of a prospective double-blind randomized study"],"prefix":"10.1038","volume":"10","author":[{"given":"Nikola","family":"Besic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaka","family":"Smrekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Branka","family":"Strazisar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,30]]},"reference":[{"key":"75961_CR1","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1111\/j.1526-4637.2009.00611.x","volume":"10","author":"K Fecho","year":"2009","unstructured":"Fecho, K. et al. Acute and persistent postoperative pain after breast surgery. Pain Med. 10, 708\u2013715 (2009).","journal-title":"Pain Med."},{"key":"75961_CR2","first-page":"1985","volume":"18","author":"R G\u00e4rtner","year":"2012","unstructured":"G\u00e4rtner, R. et al. Prevalence of and factors associated with persistent pain following breast cancer surgery. JAMA 18, 1985\u20131992 (2012).","journal-title":"JAMA"},{"key":"75961_CR3","doi-asserted-by":"publisher","first-page":"3657","DOI":"10.1200\/JCO.2006.07.4062","volume":"25","author":"A Lucci","year":"2007","unstructured":"Lucci, A. et al. Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011. J. Clin. Oncol. 25, 3657\u20133663 (2007).","journal-title":"J. Clin. Oncol."},{"key":"75961_CR4","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1023\/A:1023330206021","volume":"79","author":"J Engel","year":"2003","unstructured":"Engel, J., Kerr, J., Schlesinger-Raab, A., Sauer, H. & H\u00f6lzel, D. Axilla surgery severely affects quality of life: Results of a 5-year prospective study in breast cancer patients. Breast Cancer Res. Treat. 79, 47\u201357 (2003).","journal-title":"Breast Cancer Res. Treat."},{"key":"75961_CR5","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1007\/BF03016591","volume":"10","author":"DJ Kelly","year":"2001","unstructured":"Kelly, D. J., Ahmad, M. & Brull, S. J. Preemptive analgesia I: physiological pathways and pharmacological modalities. Can. J. Anaesth. 10, 1000\u20131010 (2001).","journal-title":"Can. J. Anaesth."},{"key":"75961_CR6","doi-asserted-by":"publisher","first-page":"e3705","DOI":"10.1097\/MD.0000000000003705","volume":"20","author":"HS Na","year":"2016","unstructured":"Na, H. S. et al. Preventive analgesic efficacy of nefopam in acute and chronic pain after breast cancer surgery: a prospective, double-blind, and randomized trial. Medicine (Baltimore) 20, e3705 (2016).","journal-title":"Medicine (Baltimore)"},{"key":"75961_CR7","doi-asserted-by":"publisher","first-page":"145","DOI":"10.2478\/raon-2013-0018","volume":"47","author":"B Strazisar","year":"2013","unstructured":"Strazisar, B. & Besic, N. Comparison of continuous local anaesthetic and systemic pain treatment after axillary lymphadenectomy in breast carcinoma patients\u2014a prospective randomized study. Radiol. Oncol. 47, 145\u2013153 (2013).","journal-title":"Radiol. Oncol."},{"key":"75961_CR8","doi-asserted-by":"crossref","first-page":"436","DOI":"10.4103\/ija.IJA_523_17","volume":"62","author":"S Kumar","year":"2018","unstructured":"Kumar, S. et al. A randomised controlled study of the post-operative analgesic efficacy of ultrasound-guided pectoral nerve block in the first 24 h after modified radical mastectomy. Indian J. Anaesth. 62, 436\u2013442 (2018).","journal-title":"Indian J. Anaesth."},{"key":"75961_CR9","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1080\/17460441.2017.1377697","volume":"12","author":"L Bravo","year":"2017","unstructured":"Bravo, L., Mico, J. & Berrocoso, E. Discovery and development of tramadol for the treatment of pain. Expert Opin. Drug Discov. 12, 1281\u20131291 (2017).","journal-title":"Expert Opin. Drug Discov."},{"key":"75961_CR10","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.biopha.2015.01.022","volume":"70","author":"M Vazzana","year":"2015","unstructured":"Vazzana, M. et al. Tramadol hydrochloride: pharmacokinetics, pharmacodynamics, adverse side effects, co-administration of drugs and new drug delivery systems. Biomed. Pharmacother. 70, 234\u2013238 (2015).","journal-title":"Biomed. Pharmacother."},{"key":"75961_CR11","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1007\/s10549-020-05713-3","volume":"182","author":"N Besic","year":"2020","unstructured":"Besic, N., Smrekar, J. & Strazisar, B. Chronic adverse effects after an axillary lymphadenectomy in breast cancer patients after administering weaker and stronger postoperative analgesia: results of a prospective double-blind randomized study. Breast Cancer Res. Treat. 182, 655\u2013663 (2020).","journal-title":"Breast Cancer Res. Treat."},{"key":"75961_CR12","doi-asserted-by":"publisher","first-page":"E352","DOI":"10.1503\/cmaj.151276","volume":"14","author":"L Wang","year":"2016","unstructured":"Wang, L. et al. Predictors of persistent pain after breast cancer surgery: a systematic review and meta-analysis of observational studies. CMAJ 14, E352\u2013E361 (2016).","journal-title":"CMAJ"},{"key":"75961_CR13","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1097\/AJP.0b013e3181cb406e","volume":"26","author":"YM Amr","year":"2010","unstructured":"Amr, Y. M. & Al-Maksoud, Y. A. A. Evaluation of efficacy of the perioperative administration of venlafaxine or gabapentin on acute and chronic postmastectomy pain. Clin. J. Pain 26, 381\u2013385 (2010).","journal-title":"Clin. J. Pain"},{"key":"75961_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jpainsymman.2018.10.496","volume":"57","author":"RM Reyad","year":"2019","unstructured":"Reyad, R. M. et al. The possible preventive role of pregabalin in postmastectomy pain syndrome: a double-blinded randomized controlled trial. J. Pain Symptom Manag. 57, 1\u20139 (2019).","journal-title":"J. Pain Symptom Manag."},{"key":"75961_CR15","doi-asserted-by":"publisher","first-page":"203","DOI":"10.2515\/therapie\/2014221","volume":"70","author":"A Roussin","year":"2015","unstructured":"Roussin, A., Doazan-d\u2019Ouince, O., G\u00e9niaux, H., Halberer, C. & French Network of Centre for Evaluation and Information on Pharmacodependence (Addictovigilance Centres). Evaluation of abuse and dependence in addiction monitoring systems: tramadol as an example. Therapie 70, 203\u2013221 (2015).","journal-title":"Therapie"},{"key":"75961_CR16","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1002\/cpdd.378","volume":"6","author":"B DeLemos","year":"2017","unstructured":"DeLemos, B. et al. Safety, tolerability, and pharmacokinetics of therapeutic and supratherapeutic doses of tramadol hydrochloride in healthy adults: a randomized, double-blind, placebo-controlled multiple-ascending-dose study. Clin. Pharmacol. Drug. Dev. 6, 592\u2013603 (2017).","journal-title":"Clin. Pharmacol. Drug. Dev."},{"key":"75961_CR17","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1046\/j.1365-2710.1999.00203.x","volume":"24","author":"D Petrone","year":"1999","unstructured":"Petrone, D., Kamin, M. & Olson, W. Slowing the titration rate of tramadol HCl reduces the incidence of discontinuation due to nausea and\/or vomiting: a double-blind randomized trial. J. Clin. Pharm. Ther. 24, 115\u2013123 (1999).","journal-title":"J. Clin. Pharm. Ther."},{"key":"75961_CR18","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.1093\/pm\/pnw317","volume":"18","author":"RA Lloyd","year":"2017","unstructured":"Lloyd, R. A., Hotham, E., Hall, C., Williams, M. & Suppiah, V. Pharmacogenomics and patient treatment parameters to opioid treatment in chronic pain: a focus on morphine, oxycodone, tramadol, and fentanyl. Pain Med. 18, 2369\u20132387 (2017).","journal-title":"Pain Med."},{"key":"75961_CR19","first-page":"217","volume":"10","author":"JL St. Sauver","year":"2017","unstructured":"St. Sauver, J. L. et al. CYP2D6 phenotypes are associated with adverse outcomes related to opioid medications. Pharmgenomics Pers. Med. 10, 217\u2013227 (2017).","journal-title":"Pharmgenomics Pers. Med."},{"key":"75961_CR20","doi-asserted-by":"publisher","first-page":"e22186","DOI":"10.1200\/JCO.2018.36.15_suppl.e22186","volume":"15","author":"N Besic","year":"2018","unstructured":"Besic, N., Dolzan, V., Goricar, K., Jeriha, J. & Strazisar, B. CYP2D6 phenotype and tramadol-related adverse events in breast cancer patients. J. Clin. Oncol. 15, e22186 (2018).","journal-title":"J. Clin. Oncol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-75961-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-75961-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-75961-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T22:17:25Z","timestamp":1670365045000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-75961-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,30]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["75961"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-75961-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,30]]},"assertion":[{"value":"23 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"N. Besic and B. Strazisar have received a research grant Trial KCT 04\/2015-doretaonko\/si from the pharmaceutical company Krka d.d. Novo mesto. J. Smrekar has received a honorarium for the statistical analysis of our study from the pharmaceutical company Krka d.d. Novo mesto.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"18766"}}